Sinovac to supply Hep A vaccine to Jiangsu province

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2013

Singapore: Sinovac Biotech, a leading China-based vaccine manufacturer, has been selected by the Jiangsu Centers for Dis...Read more

Regeneus clears procedures to initiate Progenza trial for osteoarthritis treatment

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2016

Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...Read more

Safety concerns delay launch of Pfizer's arthritis drug Xeljanz

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

Singapore: Pfizer's high hopes for its JAK3 (Janus kinase) inhibitor, tofacitinib (tasocitinib, CP-690550), now branded ...Read more

Ampio takes drug candidate to preclinical stage

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

Singapore: Ampio Pharmaceuticals has taken its candidate NCE001 from its proprietary methylphenidate derivatives family ...Read more

FDA not in favour of Otsuka's kidney drug Tolvaptan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: The US FDA Cardiovascular and Renal Drugs Advisory Committee has disapproved Japan-based Otsuka Pharmaceutic...Read more

Pfizer, Japanese firm to jointly asses mAB for tumor

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2014

Singapore: Global pharmaceutical company, Pfizer, and Japanese firm, Kyowa Hakko Kirin, are jointly assessing the therap...Read more

Hope for COPD: Network Verification Challenge

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2014

Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...Read more

Prana gets +ve results in phase II Huntington trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2014

Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...Read more

Novartis partners with TB alliance

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2014

Singapore: Novartis has partnered with Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tube...Read more

ShangPharma appoints new CSO, president

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Oct, 2013

Singapore: China's ShangPharma appointed Dr Art Taveras as president and chief scientific officer (CSO). He will be resp...Read more

NUHS chief gets Singapore President's award

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2014

Singapore: Professor John Wong Eu-Li, currently chief executive of National University Health System (NUHS), Isabel Chan...Read more

Taiwan firm gets FDA nod for ph II trial of gout drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Dec, 2014

Singapore: Taiwan based TWi Pharmaceuticals has received US FDA and Taiwan FDA approval of a protocol for a Phase II cli...Read more

BMS takes on combination drug for cancer therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2014

Singapore: Japan's Ono Pharmaceutical and Kyowa Hakko Kirin has partnered with Bristol-Myers Squibbs for Phase 1 clinica...Read more

Novartis acquires antibody technology license to develop cancer therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Oct, 2013

Singapore: Novartis has acquired the license for exclusive right to use  Antibody-Drug Conjugate (ADC) technology from ...Read more

Taiwan seeks to attract global investors

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: BioBusiness Asia concluded in Taiwan on July 18, 2013, with a message that the global biotech fraternity need...Read more

Singapore researchers get access to AstraZeneca drug compounds

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2015

Singapore: National Health Innovation Centre (NHIC) of Singapore has partnered with global pharmaceutical company, Astra...Read more

Chugai seeks approval for anti-cancer agent Avastin in Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

Singapore: Japan's Chugai Pharmaceutical filed an application with the Japanese Ministry of Health, Labour and Welfare, ...Read more

A*STAR, Japanese bank ink partnership

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2014

Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporat...Read more